PATENT CLAIM ANALYSIS

Application Number: 15757012
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "449000"]

Abstract:
The present application is directed to transdermal formulations for the delivery of doxycycline compounds to a subject for the treatment of doxycycline-responsive diseases. In particular, the transdermal formulation is an emulsion comprising an oil phase, an aqueous phase and an external phase.

Claim (Index 5):
The transdermal formulation of  claim 1 , wherein doxycycline is present in the formulation in an amount of about 0.5 wt % to about 5 wt %, or about 1 wt % to about 3 wt %, of the total formulation.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 90.0
- Lexical Diversity: 1.4375
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15623898', '13566816', '12795164', '13732024', '15168542']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.779434606184171
- 35 USC 102 Novelty (BERT): 0.4906455375268664
- Combined Prediction Score: 0.7505556993184406
- Mean Citation Score: 170.051434
- Max Citation Score: 178.84657
- Similarity Product: 118.33947258431792

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test